Compositions and methods for treating cognitive disorders

Details for Australian Patent Application No. 2005291542 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Bonhaus, Douglas William; Martin, Renee Sharon

Agent Spruson & Ferguson

Pub. Number AU-B-2005291542

PCT Pub. Number WO2006/037482

Priority 60/614,705 30.09.04 US

Filing date 22 September 2005

Wipo publication date 13 April 2006

Acceptance publication date 4 November 2010

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 31/404 (2006.01)

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/538 (2006.01)

A61K 31/5415 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/037482 Priority application(s): WO2006/037482

4 November 2010 Application Accepted

  Published as AU-B-2005291542

3 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005291557-Tantalum powder for the production of solid electrolyte capacitors

2005291541-Benzoxazine and quinoxaline derivatives and uses